InstalabChlamydia, Gonorrhoeae & Trichomonas Vaginalis
Should you take a Chlamydia, Gonorrhoeae & Trichomonas Vaginalis test?
This test is most useful if any of these apply to you.
About Chlamydia, Gonorrhoeae & Trichomonas Vaginalis
Three infections account for most of the treatable sexually transmitted disease in circulation, and all three frequently cause no symptoms at all. You can carry any of them for months while they quietly raise your risk of infertility and pregnancy complications. This panel looks for all three from one sample.
The value is in testing them together. The organism most routine screening leaves out, a parasite called Trichomonas vaginalis, is often the most common of the three, yet a standard chlamydia and gonorrhea test never looks for it.
What This Panel Reveals
The panel answers one question from three angles: which, if any, of the common curable sexually transmitted infections (STIs) you currently carry. Two are bacteria, chlamydia and gonorrhea, and the third is the trichomonas parasite. Read together, they describe your full infection picture at one moment rather than a single slice of it.
All three are found using a nucleic acid amplification test, a lab method that copies and detects an organism's genetic material. This approach is far more sensitive than older microscope-based checks. For trichomonas specifically, this kind of testing detects about one-third more infections in women than looking at a sample under a microscope alone.
The three are not equally common, and the ranking surprises people. In a United States screening study of women already being tested for chlamydia and gonorrhea, trichomonas was found in 8.7 percent, above chlamydia at 6.7 percent and gonorrhea at 1.7 percent. Trichomonas was more common than the other two in every age group except ages 18 to 19.
Most of these infections are silent. In a meta-analysis of women in low- and middle-income countries, an estimated 60.7 percent of chlamydia, 53.3 percent of gonorrhea, and 56.9 percent of trichomonas infections caused no symptoms, and other reviews put the asymptomatic share for trichomonas as high as 85 percent. The exact figures vary by population, but the pattern holds: waiting for symptoms before testing leaves most infections undetected.
How to Read Your Results Together
A single positive result is the most common pattern. Carrying two at once happens but stays in the minority, and carrying all three is uncommon. Here is how to read the combinations you are most likely to see.
| Your Result Pattern | What It Suggests |
|---|---|
| One organism positive | The usual pattern. That single infection is treatable with antibiotics; your partners need treatment too, and you should retest in about three months. |
| Trichomonas positive, bacteria negative | Common, and more likely over age 40. Trichomonas is easy to miss on standard testing, so this is exactly the case the panel is built to catch. |
| Two organisms positive | A real but less common coinfection. Each infection needs its own treatment, and both should be confirmed cleared later. |
| All negative but symptoms persist | Reassuring for these three, but a urine sample can miss infection at other sites, and this panel does not cover syphilis, herpes, or HIV. |
What to Do with Your Results
A positive result is good news in one sense: all three infections are curable with antibiotics. The two priorities are treating any sexual partners so you are not reinfected, and rescreening in about three months, because a new infection in the year after a first one is common. If a partner is not treated, a later positive often reflects reinfection rather than failed treatment.
Because these three do not cover the full range of STIs, pair this panel with a syphilis blood test and an HIV test for a fuller picture. Any of these infections can raise the risk of acquiring HIV, which is another reason to test broadly. One caution on gonorrhea: this test confirms the infection is present but does not measure which antibiotics will work, so treatment follows current resistance guidance.
When Results Can Be Misleading
This panel uses a urine sample. In women, a vaginal swab detects more infection than urine does, with sensitivity of 98.0 percent versus 95.1 percent for trichomonas and an even larger gap for chlamydia (94.1 versus 86.9 percent) and gonorrhea (96.5 versus 90.7 percent). A negative urine result is reassuring for the urogenital tract but does not test the throat or rectum, which can carry chlamydia or gonorrhea on their own.
Timing after treatment matters. These tests detect genetic material, and leftover material can keep a result positive for a few weeks after the infection is actually gone. If you are checking that treatment worked, waiting three to four weeks, depending on the organism and the treatment used, avoids a false alarm. A retest sooner than that can misread a cure as a persistent infection.